<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03191669</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0169</org_study_id>
    <nct_id>NCT03191669</nct_id>
  </id_info>
  <brief_title>Vaccine Exposure in Patients With MS</brief_title>
  <acronym>Enquête Vaccin</acronym>
  <official_title>Vaccine Exposure in Patients With Multiple Sclerosis in the Auvergne-Rhone-Alpes Region</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vaccines in MS patients have been controversial, in particular hepatitis B vaccine in the 90s
      and more recently human papillomavirus vaccine. There was an important flu incidence during
      the winter 2016-2017 that has revealed a low exposure to the flu vaccine in health
      professionals in France. Vaccine exposure of Multiple sclerosis (MS) patients has not been
      evaluated yet.

      Objectives The primary objective is to evaluate exposure to the flu vaccine in patients with
      MS during the 2016-17 campaign. Secondary objectives are to evaluate exposure to mandatory
      vaccines, non mandatory vaccines, in the context of immunoactive treatments; to identify
      potential limitations to vaccines in general in patients with MS.

      Methods Cross-sectional observational multicentric study, performed in Auvergne-Rhône-Alpes
      (France).

      Data will be collected through an auto-questionnaire administered during an out-patient visit
      or hospitalization, during a two-week period.

      Statistical analysis Description of the percentage of patients exposed to the flu vaccine,
      and to other vaccines. Stratification according to demographics (age, sex) and MS related
      criteria (disability level, relapse in the year before, disease-modifiying drug) Expected
      results Vaccine exposure of patients with MS will be put in perspective with the general
      population exposure. The study can provide information regarding potential reluctance of
      patients with MS towards vaccines. This could lead to develop specific communication tools
      for patients with MS and/or health professionals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 26, 2017</start_date>
  <completion_date type="Actual">July 7, 2017</completion_date>
  <primary_completion_date type="Actual">July 7, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients exposed to seasonal flu vaccine in 2016-2017</measure>
    <time_frame>Two-weeks period in July 2017</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">335</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>MS patients</arm_group_label>
    <description>Single group of patients with MS attending an outpatient MS clinic or hospitalization</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Auto-questionnaire</intervention_name>
    <description>Single Auto-questionnaire administered during or after a consultation/hospitalization</description>
    <arm_group_label>MS patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with MS attending an outpatient MS clinic or hospitalization
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Multiple sclerosis according to MacDonald 2010 criteria

          -  Age 18 and more

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra VUKUSIC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Neurologique Pierre Wertheimer - GHE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Neurologique Pierre Wertheimer</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie - Hôpital G. Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie - CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie - Hôpital Saint Joseph Saint Luc</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet de Neurologie - Clinique de la Sauvegarde</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie - Hôpital Nord - CHU St Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2017</study_first_submitted>
  <study_first_submitted_qc>June 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2017</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

